文献速递瓣膜外科

微创二尖瓣修复中再次阻断的早期结局与危险因素:倾向性匹配队列分析

Early Outcomes and Risk Factors Associated With Second Cross-clamping in Mitral Valve Repair: A Propensity-matched Minimally Invasive Cohort Analysis.
PubMed 文献 · Eur J Cardiothorac Surg · 2025-01-01

倾向性匹配后比较显示,再次阻断组体外循环和主动脉阻断时间更长、通气和ICU停留更久,但中期生存无显著差异。复杂瓣膜病理和瓣叶限制是再次阻断的预测因素。

要点

  • 微创二尖瓣修复中再次阻断发生率为4.4%,主要原因为残余二尖瓣反流。
  • 再次阻断不增加中期死亡风险,但延长通气和ICU停留时间。
  • 退行性病变复杂瓣膜病理和功能性瓣叶限制是再次阻断的预测因素。

核心结论

  • 再次阻断可安全实施,不损害早期和中期术后结局。
  • 退行性二尖瓣反流复杂瓣膜病理和功能性二尖瓣反流瓣叶限制的患者再次阻断风险更高。

研究设计与样本

  • 单次阻断组与再次阻断组按年龄、性别、二尖瓣反流病因及基线特征进行1:1倾向性匹配。
  • 采用逻辑回归识别再次阻断预测因素,Kaplan-Meier生存分析比较中期结局。

主要发现

  • 1732例中76例(4.4%)需再次阻断,主要原因为残余二尖瓣反流。
  • 退行性病变复杂瓣膜病理比值比3.386(P=.005),功能性病变瓣叶限制比值比8.00(P=.014),但多变量回归未证实为独立预测因素。
  • 再次阻断组体外循环时间149.5 vs 99.5分钟,主动脉阻断时间96.0 vs 60.0分钟(P<.001)。
  • 再次阻断组通气时间17.0 vs 12.5小时,ICU停留32.0 vs 24.0小时(P<.001)。
  • 中期结局两组无差异(74.4% vs 84.6%,log-rank P=.07)。

临床怎么用

  • 对退行性二尖瓣反流复杂瓣膜病理或功能性二尖瓣反流瓣叶限制患者,应预期再次阻断可能并做好相应准备。
  • 再次阻断虽延长通气和ICU停留,但不影响中期生存,可安全实施。

局限性

  • 为单中心回顾性研究,存在选择偏倚可能。
  • 复杂瓣膜病理和瓣叶限制在多变量回归中未证实为独立预测因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Second cross-clamping (2nd XCL) is infrequently required in patients undergoing mitral valve repair (MVr), mostly due to unsatisfactory initial repair results. This study investigated risk factors for 2nd XCL and compared early and mid-term outcomes in a propensity-matched cohort undergoing minimally invasive MVr (MI-MVr). METHODS: A retrospective review of patients undergoing MI-MVr for degenerative mitral regurgitation (DMR) or functional mitral regurgitation (FMR) between October 2014 and March 2024 was performed. Patients with a single vs 2nd XCL were matched 1:1 based on age, gender, MR aetiology, and other baseline characteristics. Echocardiographic assessments, surgical techniques, and postoperative outcomes were analysed. Logistic regression identified predictors for 2nd XCL, and Kaplan-Meier survival analysis compared mid-term outcomes. RESULTS: Out of 1732 patients, 76 (4.4%) required 2nd XCL. The primary reason for 2nd XCL was residual MR. Complex valve pathology in DMR (odds ratio 3.386, P = .005) and leaflet restriction in FMR (odds ratio 8.00, P = .014) were identified as predictors for 2nd XCL but were not confirmed as independent predictors in multivariable regression analysis. The 2nd XCL group had longer cardiopulmonary bypass and aortic cross-clamp times (149.5 vs 99.5 min and 96.0 vs 60.0 min, respectively; P < .001). No differences were observed in midterm outcomes between the 2nd XCL and control groups (74.4% vs 84.6%, log-rank P = .07), except for prolonged length of ventilation time and intensive care unit stay (17.0 vs 12.5 hours and 32.0 vs 24.0 hours, P < .001, respectively). CONCLUSIONS: 2nd XCL can be performed safely without impairing early and mid-term postoperative outcomes. Patients with complex valve pathology in DMR and leaflet restriction in FMR are at a higher risk for 2nd XCL.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Akansel S, Dini M, Pitts L, et al. Early Outcomes and Risk Factors Associated With Second Cross-clamping in Mitral Valve Repair: A Propensity-matched Minimally Invasive Cohort Analysis. Eur J Cardiothorac Surg. 2025. PMID: 41284694. doi:10.1093/ejcts/ezaf421

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。